Skip to content

PPH

VanEck Pharmaceutical ETF

ETF

$108.06−0.08 (−0.07%)Close Oct 2, 2026

Adjusted price

+18.15% total return, past year

Key statistics

Expense ratio
0.36%
52-week range
$90.97$117.87
From all-time high
−8.32%
Max drawdown
−46.45%
Volatility
18.26%
Sharpe ratio
0.42
Beta (5Y monthly)
0.45
Median dollar volume
$23.4M
First close
Feb 1, 2000

Total

1M
−6.1%
YTD
+6.6%
1Y
+18.2%

Per year

3Y
+13.2%
5Y
+10.3%
10Y
+8.6%
20Y
+8.2%
Since 2000
+6.1%

Fund facts

As of Jun 30, 2026
Net assets
$879M
Holdings
26
Top 10 holdings
72.7%
Stocks
99.5%

Sectors

Health Care
91.3%
Consumer Staples
3.1%
Information Technology
2.1%
Other
3.1%

Top holdings

HoldingWeight (%)
LLYEli Lilly and Company20.2
NVSNovartis AG10.6
MRKMerck & Co., Inc.9.8
NVONovo Nordisk A/S5.4
ABBVAbbVie Inc.4.6
PFEPfizer Inc.4.5
BMYBristol-Myers Squibb Company4.5
GSKGSK plc4.4
JNJJohnson & Johnson4.4
AstraZeneca PLC4.3

Annual returns

2000 from Feb 1 · 2026 through Oct 2